These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30381262)

  • 1. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
    González I; Goyal B; Xia MD; Pai RK; Ma C
    Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma.
    Ge H; Xiao Y; Qin G; Gu Y; Cai X; Jiang W; Tu X; Yang W; Bi R
    Diagn Pathol; 2021 Feb; 16(1):12. PubMed ID: 33541386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma.
    Lowenthal BM; Nason KS; Pennathur A; Luketich JD; Pai RK; Davison JM; Ma C
    Hum Pathol; 2019 Dec; 94():1-10. PubMed ID: 31655170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency.
    Chou A; Toon CW; Clarkson A; Sioson L; Houang M; Watson N; DeSilva K; Gill AJ
    Hum Pathol; 2014 Aug; 45(8):1697-703. PubMed ID: 24925223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
    Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
    Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency.
    Xia M; Singhi AD; Dudley B; Brand R; Nikiforova M; Pai RK
    Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):399-406. PubMed ID: 27258561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
    Li Z; Wang Y; Ying X; Zhang L; Gao X; Jia Y; Zhang L; Wu A; Su X; Ji J
    J Surg Oncol; 2021 Dec; 124(8):1356-1364. PubMed ID: 34515995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
    Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
    World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
    Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].
    Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):591-6. PubMed ID: 26714599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair.
    Alex AK; Siqueira S; Coudry R; Santos J; Alves M; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2017 Sep; 16(3):228-239. PubMed ID: 28063788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel Adenocarcinoma.
    Latham A; Shia J; Patel Z; Reidy-Lagunes DL; Segal NH; Yaeger R; Ganesh K; Connell L; Kemeny NE; Kelsen DP; Hechtman JF; Nash GM; Paty PB; Zehir A; Tkachuk KA; Sheikh R; Markowitz AJ; Mandelker D; Offit K; Berger MF; Cercek A; Garcia-Aguilar J; Saltz LB; Weiser MR; Stadler ZK
    Clin Cancer Res; 2021 Mar; 27(5):1429-1437. PubMed ID: 33199489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics and Outcomes of Treatment in Patients with Stage IV Colorectal Cancer with Mismatch Repair Deficiency].
    Ishibashi K; Chika N; Suzuki O; Ito T; Amano K; Kumamoto K; Fukuchi M; Kumagai Y; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1711-1714. PubMed ID: 28133107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
    Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
    Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.
    Koopman M; Kortman GA; Mekenkamp L; Ligtenberg MJ; Hoogerbrugge N; Antonini NF; Punt CJ; van Krieken JH
    Br J Cancer; 2009 Jan; 100(2):266-73. PubMed ID: 19165197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of mismatch repair deficiency in gallbladder cancer.
    Goeppert B; Roessler S; Renner M; Loeffler M; Singer S; Rausch M; Albrecht T; Mehrabi A; Vogel MN; Pathil A; Czink E; Köhler B; Springfeld C; Rupp C; Weiss KH; Schirmacher P; von Knebel Doeberitz M; Kloor M
    Diagn Pathol; 2019 May; 14(1):36. PubMed ID: 31068195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
    Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
    World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer.
    Vlahović I; Rajc J; Švagelj I; Šolić K; Švagelj D
    Pathol Oncol Res; 2023; 29():1610908. PubMed ID: 37325467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.